Trial Profile
The effects of tolvaptan treatment and copeptin concentration on renal prognosis in patients with chronic kidney disease or nephrotic syndrome, who have heart failure symptoms.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2014
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Kidney disorders; Nephrotic syndrome
- Focus Adverse reactions
- 30 Aug 2014 New trial record